NO177263C - Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivaterInfo
- Publication number
- NO177263C NO177263C NO904822A NO904822A NO177263C NO 177263 C NO177263 C NO 177263C NO 904822 A NO904822 A NO 904822A NO 904822 A NO904822 A NO 904822A NO 177263 C NO177263 C NO 177263C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- pyridine derivatives
- analogous process
- active pyridine
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU895807A HU207047B (en) | 1989-11-07 | 1989-11-07 | Process for producing new pyridine derivatives and pharmaceutical copositions comprising same |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO904822D0 NO904822D0 (no) | 1990-11-06 |
| NO904822L NO904822L (no) | 1991-05-08 |
| NO177263B NO177263B (no) | 1995-05-08 |
| NO177263C true NO177263C (no) | 1995-08-16 |
Family
ID=10970765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO904822A NO177263C (no) | 1989-11-07 | 1990-11-06 | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5155123A (enEXAMPLES) |
| EP (1) | EP0427526B1 (enEXAMPLES) |
| JP (1) | JPH03169862A (enEXAMPLES) |
| KR (1) | KR910009663A (enEXAMPLES) |
| CN (1) | CN1052305A (enEXAMPLES) |
| AR (1) | AR248394A1 (enEXAMPLES) |
| AT (1) | ATE109137T1 (enEXAMPLES) |
| AU (1) | AU631261B2 (enEXAMPLES) |
| CA (1) | CA2029222A1 (enEXAMPLES) |
| DE (1) | DE69011046T2 (enEXAMPLES) |
| DK (1) | DK0427526T3 (enEXAMPLES) |
| ES (1) | ES2057441T3 (enEXAMPLES) |
| FI (1) | FI905493A7 (enEXAMPLES) |
| HU (1) | HU207047B (enEXAMPLES) |
| IL (1) | IL96252A (enEXAMPLES) |
| IN (1) | IN171700B (enEXAMPLES) |
| NO (1) | NO177263C (enEXAMPLES) |
| NZ (1) | NZ235984A (enEXAMPLES) |
| PH (1) | PH27440A (enEXAMPLES) |
| ZA (1) | ZA908889B (enEXAMPLES) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE496032T1 (de) | 1999-02-24 | 2011-02-15 | Hoffmann La Roche | 4-phenylpyridinderivate und deren verwendung als nk-1 rezeptorantagonisten |
| US7288658B2 (en) | 2003-07-15 | 2007-10-30 | Hoffmann-La Roche Inc. | Process for preparation of pyridine derivatives |
| MY143784A (en) | 2005-09-23 | 2011-07-15 | Hoffmann La Roche | Novel dosage formulation |
| CN102892290B (zh) * | 2010-08-31 | 2016-02-03 | 明治制果药业株式会社 | 有害生物防除剂 |
| CA2844916A1 (en) * | 2011-08-26 | 2013-03-07 | Meiji Seika Pharma Co., Ltd. | Method for producing pest control agent |
| US20210238176A1 (en) | 2018-08-07 | 2021-08-05 | Syngenta Crop Protection Ag | Pesticidally-active bicyclic heteroaromatic compounds |
| AR117291A1 (es) | 2018-12-14 | 2021-07-28 | Syngenta Crop Protection Ag | Compuestos heterocíclicos de cianamida con actividad pesticida |
| WO2020169526A1 (en) | 2019-02-18 | 2020-08-27 | Syngenta Crop Protection Ag | Pesticidally-active cyanamide heterocyclic compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1201119A (en) * | 1978-09-18 | 1986-02-25 | Mcneilab, Inc. | Diaza-cyclic derivatives of guanidine |
| HU188852B (en) * | 1983-03-16 | 1986-05-28 | Richter Gedeon Vegyeszeti Gyar Rt,Hu | Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer |
| JPH07121909B2 (ja) * | 1986-09-10 | 1995-12-25 | 日本バイエルアグロケム株式会社 | 新規複素環式化合物及び殺虫剤 |
-
1989
- 1989-11-07 HU HU895807A patent/HU207047B/hu unknown
-
1990
- 1990-10-31 US US07/607,153 patent/US5155123A/en not_active Expired - Fee Related
- 1990-11-02 CA CA002029222A patent/CA2029222A1/en not_active Abandoned
- 1990-11-06 AU AU65823/90A patent/AU631261B2/en not_active Ceased
- 1990-11-06 KR KR1019900017881A patent/KR910009663A/ko not_active Withdrawn
- 1990-11-06 JP JP2299084A patent/JPH03169862A/ja active Pending
- 1990-11-06 NZ NZ235984A patent/NZ235984A/en unknown
- 1990-11-06 NO NO904822A patent/NO177263C/no unknown
- 1990-11-06 PH PH41502A patent/PH27440A/en unknown
- 1990-11-06 ZA ZA908889A patent/ZA908889B/xx unknown
- 1990-11-06 IL IL9625290A patent/IL96252A/en not_active IP Right Cessation
- 1990-11-06 FI FI905493A patent/FI905493A7/fi not_active Application Discontinuation
- 1990-11-06 AR AR90318303A patent/AR248394A1/es active
- 1990-11-06 IN IN930/CAL/90A patent/IN171700B/en unknown
- 1990-11-07 DE DE69011046T patent/DE69011046T2/de not_active Expired - Fee Related
- 1990-11-07 DK DK90312167.1T patent/DK0427526T3/da active
- 1990-11-07 CN CN90109755A patent/CN1052305A/zh active Pending
- 1990-11-07 AT AT90312167T patent/ATE109137T1/de not_active IP Right Cessation
- 1990-11-07 EP EP90312167A patent/EP0427526B1/en not_active Expired - Lifetime
- 1990-11-07 ES ES90312167T patent/ES2057441T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0427526A1 (en) | 1991-05-15 |
| AR248394A1 (es) | 1995-08-18 |
| DE69011046D1 (de) | 1994-09-01 |
| HU895807D0 (en) | 1990-01-28 |
| NO904822L (no) | 1991-05-08 |
| ZA908889B (en) | 1991-10-30 |
| DE69011046T2 (de) | 1994-11-24 |
| NO904822D0 (no) | 1990-11-06 |
| US5155123A (en) | 1992-10-13 |
| HUT55758A (en) | 1991-06-28 |
| IL96252A0 (en) | 1991-08-16 |
| DK0427526T3 (da) | 1994-08-29 |
| NZ235984A (en) | 1992-08-26 |
| NO177263B (no) | 1995-05-08 |
| KR910009663A (ko) | 1991-06-28 |
| FI905493A0 (fi) | 1990-11-06 |
| IL96252A (en) | 1994-12-29 |
| ES2057441T3 (es) | 1994-10-16 |
| AU631261B2 (en) | 1992-11-19 |
| AU6582390A (en) | 1991-05-23 |
| CN1052305A (zh) | 1991-06-19 |
| IN171700B (enEXAMPLES) | 1992-12-12 |
| PH27440A (en) | 1993-07-02 |
| ATE109137T1 (de) | 1994-08-15 |
| EP0427526B1 (en) | 1994-07-27 |
| CA2029222A1 (en) | 1991-05-08 |
| HU207047B (en) | 1993-03-01 |
| JPH03169862A (ja) | 1991-07-23 |
| FI905493A7 (fi) | 1991-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
| FI883739A7 (fi) | Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi | |
| NO163131C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater. | |
| NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO177387C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser | |
| NO175478C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive diazepin-derivater | |
| NO176319C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater | |
| FI900886A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi | |
| FI875660L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi | |
| FI875024A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1-alkyyli-6-halogeenitetrahydronaftaleenijohdannaisten valmistamiseksi | |
| NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
| NO174467C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO178543C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater | |
| NO176713C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater | |
| NO176275C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater | |
| NO178068C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive tiazolidindionderivater | |
| FI891003A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 6-substituoitujen purinyylipiperatsiinijohdannaisten valmistamiseksi | |
| NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
| FI906408L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi | |
| NO174959C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater | |
| FI894604L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyridyyli- ja pyrimidyylipiperatsiinijohdannaisten valmistamiseksi | |
| NO174391C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater | |
| FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia |